LENZ Therapeutics's market cap is currently $646.00M. The company's EPS TTM is $-7.07; its P/E ratio is ―; LENZ Therapeutics is scheduled to report earnings on May 7, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 15.00M	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -2.41M	$ 6.65M	$ -734.00K	$ -121.00K	$ 0.00
Operating Income	$ -73.11M	$ -105.64M	$ -60.44M	$ -13.50M	$ -29.00K
EBITDA	$ -122.24M	$ -97.29M	$ -70.03M	$ -68.21M	$ -29.00K
Net Income	$ -124.65M	$ -101.05M	$ -70.76M	$ -68.37M	$ -109.00K
Balance Sheet
Cash & Short-Term Investments	$ 185.86M	$ 268.23M	$ 376.98M	$ 19.82M	$ 6.00K
Total Assets	$ 188.46M	$ 321.90M	$ 401.99M	$ 22.56M	$ 6.00K
Total Debt	$ 362.00K	$ 5.79M	$ 0.00	$ 0.00	$ 2.21M
Net Debt	$ -185.50M	$ -41.94M	$ -376.98M	$ -19.82M	$ 2.20M
Total Liabilities	$ 4.87M	$ 25.61M	$ 12.14M	$ 32.36M	$ 2.22M
Stockholders' Equity	$ 183.58M	$ 296.29M	$ 389.84M	$ -9.80M	$ -2.22M
Cash Flow
Free Cash Flow	$ -100.86M	$ -94.57M	$ -58.59M	$ -10.27M	$ -19.00K
Operating Cash Flow	$ -90.01M	$ -87.98M	$ -52.85M	$ -8.72M	$ -19.00K
Investing Cash Flow	$ 226.35M	$ -241.86M	$ -5.74M	$ -1.54M	$ 0.00
Financing Cash Flow	$ 190.00K	$ 597.00K	$ 417.47M	$ 30.08M	$ 0.00

Currency in USD

LENZ Therapeutics Earnings and Revenue History

Income Statement >

LENZ Therapeutics Debt to Assets

Balance Sheet >

LENZ Therapeutics Cash Flow

Cash Flow >

LENZ Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing